NCT05333471View on ClinicalTrials.gov

Fecal Microbiota Transplantation for Chronic Granulomatous Disease-Associated Colitis

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 8, 2022

Primary Completion Date

December 1, 2025

Study Completion Date

March 1, 2026

Conditions
Chronic Granulomatous Disease-associated Colitis
Interventions
DRUG

MTP 101-LF

Each unit of MTP-101-LF contains approximately 35 mL of fecal transplant product. Participants will receive approximately 32 mL via colonoscopy.

Trial Locations (1)

20892

RECRUITING

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH